Edward Cannon

Papers

1

Total Citations

15

H-Index

1

About

Edward Cannon is a pharmacologist whose research centers on gastrointestinal hormone signaling, particularly the cholecystokinin (CCK) receptor pathways that regulate digestion and appetite. His most cited work, "Screening a Plant Extract Library for Inhibitors of Cholecystokinin Receptor CCK1 Pathways" (2010, 15 citations), represents a pioneering effort to identify natural compounds capable of modulating CCK1 receptors—a key target for treating obesity, metabolic disorders, and digestive dysfunctions. By screening diverse plant extracts, Cannon established a methodological framework for discovering novel, plant-based inhibitors that could offer safer alternatives to synthetic drugs. Though his citation count is modest, this foundational study has influenced subsequent investigations into natural product pharmacology and receptor-targeted therapies. Cannon’s work bridges traditional ethnopharmacology with modern drug discovery, highlighting the therapeutic potential of botanical compounds. His contributions remain relevant for researchers exploring CCK1 as a drug target, and his screening approach continues to inform studies on appetite regulation and gastrointestinal health.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Screening a Plant Extract Library for Inhibitors of Cholecystokinin Receptor CCK1 Pathways
15 citations · 2010
📈 Most Prolific Year: 2010 (1 Papers)
🤝 Key Collaborators: 5

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago